Principality of Monaco: Mark Mawson awarded with FUTURUM PRIZE by Prince Albert II of Monaco
It was September 2010 when the newly established Monegasque Futurum association - founded by architect Kawther Al Abood – organized his first three activities. Held from the 23rd to 26th they welcomed eminent experts and scientists from the MIT (Massachusetts Institute of Technology) for an exceptional business meeting entitled ‘Energy Forum.’
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181030005661/en/
BOARD OF DIRECTORS FUTURUM ASSOCIATION with H.S.H Prince Albert II of Monaco and the artist Mark Mawson (From left Mahmoud Al Abood, M. Régis Bergonzi, M Lars Ericson, SAS LE PRINCE ALBERT II - Honorary President Futurum -, M. Mark Mawson and Kawther Al Abood - President Futurum) Copyright Gaetan LUCI /Palais Princier de Monaco
At the same time, in Monaco, the association arranged the world premiere of 'Death and the Powers,' a new opera produced at the MIT Media Lab by American composer Tod Machover, thanks to Futurum who partnered his creation.
It marked the start of Futurum’s activities, strictly related to the association’s objectives to develop, promote and encourage ‘futuristic' events in the world of art and science. Every year since then, Futurum has shared with its members many original initiatives, such as exclusive gala evenings or private visits to major art museums, always with the aim of discovering and appreciating artists able to combine their talents with innovative technologies.
In 2013, the prestigious 'Futurum Award' was established, the trophy being a replica of the sculpture 'La vague de l'amour,' produced by the President himself (the original work is part of the permanent collection exhibited in Cap Martin Park in Roquebrune Cap Martin).
Selected by the Futurum Board of Directors, the prize has been awarded each year to an emerging artist or an artist already recognised worldwide for their ability to combine art, talent and new technologies.
To date, the prize has been presented five times, at an exclusive evening attended by HSH Prince Albert II, Honorary President of Futurum, where mainly internationally renowned guests are invited to share their experiences with the audience.
Following the success last year of American glass sculptor Dale Chihuly, Futurum’s Board of Directors, comprising President Kawther Al Abood, Régis Bergonzi (Vice-President), Lars H. Ericson (Secretary) and Mahmoud Al Abood (Treasurer) have decided to present this year’s prestigious Futurum Award to the internationally renowned English photographer, Mark Mawson. He has been invited to attend the ceremony held in Monaco on 25th October 2018.
“Once again, choosing the winner was not easy," said President Al Abood, who adds: "We analysed about ten candidates and all of them were particularly brilliant and authors of work created thanks to the support and use of new technologies. In the end it was Mawson's talent and creations that won us all over, with his colours and ability to interpret abstract concepts through the use of innovative techniques. For this reason I was really happy to welcome him to Monaco and present some of his works at the 6 th Futurum Awards Gala that has been considered an unforgettable event in Monte-Carlo.”
ABOUT FUTURUM: The association aims to encourage and promote futuristic projects in all the Arts, including Science (as an Art), at an international level, encouraging the participation of a young generation of artists and scientists, in all of the domains that affect everyday life. WEBSITE: http://www.associationfuturum.com
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
LTI Acquires Ruletronics, a Boutique Pega® Consulting Company17.1.2019 11:08 | Pressemelding
Larsen & Toubro Infotech Ltd. (NSE: LTI, BSE: 540005), a global technology consulting and digital solutions company has acquired Ruletronics, a pure-play Pega® consulting and implementation company with offices in the UK, USA, and India. Ruletronics enables businesses to transform and evolve digitally by providing innovative BPM and CRM solutions leveraging Pega Platform. Their current industry strength lies across Insurance, Banking, Healthcare and Retail segments. The company offers unique product based offerings for Disability Claims management, KYC Bulk Remediation, and Insurance Sales & Service applications. The acquisition will strengthen LTI’s rapidly growing digital business with a suite of capabilities in Pega implementation space around establishing BPM Roadmap & Strategy, Customer Services, RPA and Decisioning. Nachiket Deshpande, COO, LTI, said: “Pega is a leader in Intelligent Business Process Management segment with more than 3,000 customers globally. Ruletronics brings s
Formetrix Hires CEO and Commits to New Headquarters in Greater Boston17.1.2019 11:05 | Pressemelding
Formetrix, Inc., a designer and producer of proprietary, high-performance, steel alloys for additive manufacturing, has named Scott Pearson as its new Chief Executive Officer. The Company also announces that it has committed to a new headquarters in the greater Boston area with occupancy scheduled to occur in March. “We are thrilled to attract someone of Scott’s caliber and experience to lead Formetrix as we enter our next phase of growth,” said K. Leonard Judson, a Formetrix Director and the President and Managing Director of Cycad Group. Judson continued, “Scott is the ideal person to drive the Company’s growth and operational strategies, to establish mutually beneficial partnerships with industry and customers, and to establish the company as a leader in the rapidly developing additive manufacturing materials space.” “I am excited to join the Formetrix team and to lead the organization as we target the opportunities that exist in the 3D printing market today for our world-class, ste
AGCO Focuses on Animal Welfare17.1.2019 10:00 | Pressemelding
AGCO (NYSE: AGCO), a global leader in manufacturing and the distribution of agricultural equipment and solutions, today hosted its annual AGCO Berlin Summit. The international industry event aims to bring together decision-makers in politics, economy and society to share their experiences and discuss the future of the agricultural industry. Today’s ‘Feeding the World - The Future for Protein’ summit was focused on aspects of animal welfare in the context of modern agriculture, including the need for sustainable protein production to meet an increasing demand for protein-rich foods. The AGCO Berlin Summit is a joint initiative of AGCO and the new AGCO Agriculture Foundation. The AGCO Agriculture Foundation develops charitable initiatives to enhance global food security, sustainable agricultural development and positive economic impacts, particularly in developing countries. As in previous years, AGCO Finance and AGCO Fuse Technologies are sponsors of the 2019 AGCO Berlin Summit. "Whilst
Mr. Paul Bridwell Joins OpenGate Capital in Senior Operations Role for North America17.1.2019 08:00 | Pressemelding
OpenGate Capital, a global private equity firm, announced that Mr. Paul Bridwell joined the firm on November 5th, 2018, as Managing Director to lead operations and portfolio management for the firm’s North American-based investments. Based in Los Angeles, Bridwell joins the OpenGate senior leadership team as a member of the firm’s Investment and Portfolio Committees. Bridwell is a tenured professional with 15 years of private equity experience and has a proven track record of delivering operating results leading to superior investor returns. He possesses solid leadership and organizational skills both as portfolio company CEO and as an operations leader developed through his tenure at two global, private equity firms. Prior to joining OpenGate, Bridwell was Partner and Managing Director – Head of Operations at a major private equity investment firm in New York City, where he established the firm’s first operations-focused group and developed a comprehensive operations approach compatib
Anywhere365 Introduces Web Agent for Microsoft Dynamics 36517.1.2019 07:00 | Pressemelding
Workstreampeople, a global leader in contact center solutions for Skype for Business and Microsoft Teams, today announced the introduction of the Anywhere365 Web Agent for Microsoft Dynamics 365. Based on the Dynamics 365 Channel Integration Framework (CIF) the Web Agent is nested in the Dynamics 365 interface and provides users with Anywhere365’s omni-channel contact center functionality without having to move between applications. The Dynamics 365 client is automatically resized to accommodate the Web Agent ensuring none of the user interface is masked. Agents can receive, send, and automatically log calls, chats, emails and video all from within Dynamics 365, improving the efficiency and accuracy of customer interactions. From the Anywhere365 Web Agent, Dynamics 365 users can control media interactions and monitor real-time queue information. Integration with Microsoft Azure services provides automatic language detection and real-time translation of chat and voice interactions betwe
Ipsen Presents the Results of the First in-Human Study of a Recombinant Fast-Acting Neurotoxin (rBoNT-E) at TOXINS 201917.1.2019 06:30 | Pressemelding
Regulatory News: Results of the first in-human study of a recombinant neurotoxin are being presented at the TOXINS International Conference in Copenhagen. Ipsen’s recombinant BoNT serotype E (rBoNT-E) was investigated in a phase I study that demonstrated its safety and tolerability profile in healthy volunteers1. The study also reported that it has a faster onset of action and a shorter duration of effect, as well as a quick time to peak activity, in comparison with established BoNT-A products. Further studies will be initiated to establish potential aesthetic and therapeutic uses of this investigational therapy. “The application of recombinant techniques to create novel botulinum toxin-based medicines with different onsets and durations of action, will potentially offer clinicians the flexibility to choose the most appropriate neurotoxin for each patient, which is not an option today,” said Philippe Picaut, Pharm. D., PhD, Senior Vice President Research & Development for the Neuroscie